Since then, more than 850 orphan drug designations have been granted by the European Commission based on a positive opinion from the Committee for Orphan Medicinal Products (COMP), and more than 60 orphan drugs have received marketing authorization in Europe. Here, stimulated by the tenth ...
Overview & Products Alternatives & Competitors Founded Year 1958 About European Commission The European Commission's Covenant of Mayors - Europe initiative focuses on local climate and energy actions within the environmental sector. It offers a framework for cities to commit to and report on their ene...
RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 t...
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy for New First-Line Indications in Advanced HER2-Negative Gastric or GEJ Adenocarcinoma in Tumors Expressing PD-L1 (CPS ≥1) and Advanced Biliary ...
The European Commission approved the first aflibercept biosimilar, which will be used to treat patients with age-related macular degeneration and diabetic macular edema.
The European Commission approval follows a positive opinion granted in June 2021 by the European Medicines Agency’s Committee for Medicinal Products for Human Use. The approval is supported by positive results from three Phase 3 st...
The decision from the European Commission follows a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on 24 July 2014.2 This approval allows for the marketing of IMBRUVICA in all 28 countries of the European Union. Link to ...
“The European Commission’s decision to approve ALUNBRIG for patients with ALK+ NSCLC is a significant advancement for European patients impacted by this life-threatening disease,” said Jesús Gómez-Navarro, M.D., Vice President, Head of Oncology Clinical Research and Development, Takeda. “This...
The European Commission Grants Marketing Authorization to Bracco Imaging for Vueway (gadopiclenol) Contrast Agent in the European Union Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by...
"I want to thank the European Commission for its engagement and endorsement and the EMA for its recommendation, which is another significant moment in our company's history," said Stéphane Bancel, Chief Executive Officer of Moderna. "The EMA and the Committee for Medicinal Products for Human...